Acasti Pharma

Acasti Pharma is a biopharmaceutical company based in Canada. Co. is engaged in the research, development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment and prevention of cardiovascular disorders. Co.'s products are derived from krill oil. Co.'s products include: CaPre® is for prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia; and Onemia™ is for cardiometabolic disorders treatments. Co. sells its products primarily in Canada and the U.S.
  • TickerAPO.RT
  • ISINCA00430K4028
  • SectorPharmaceuticals & Biotechnology
  • CountryCanada

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Toronto Quantitative Stock Report for ACST

ValuEngine Rating and Forecast Report for ACST

ValuEngine Rating and Forecast Report for ACST

ResearchPool Subscriptions

Get the most out of your insights

Get in touch